Literature DB >> 18652883

Effect of particle properties on the flowability of ibuprofen powders.

L X Liu1, I Marziano, A C Bentham, J D Litster, E T White, T Howes.   

Abstract

Powder flowability is one of the key parameters in the pharmaceutical tabletting process. The flowability is affected by both the particles' properties and the tabletting equipment characteristics. Although it is generally accepted that powder flowability increases with an increase in particle size, quantitative studies and comprehensive theoretical insights into the particle property effects are still lacking. In this paper, ibuprofen, a non-steroidal drug widely used as an anti-inflammatory analgesic was chosen as a model material to assess the effect of particle properties on its flowability. Ibuprofen typically has a needle shaped morphology. The flowability of ibuprofen size fractions was studied in detail using two flow measurement methods. The separated fractions were also compared to magnesium stearate lubricated ibuprofen and its size fractions. The experimental results showed that powder flowability is significantly affected by both the particle size and size distribution. The finest size fraction that is separated from the bulk ibuprofen powder flows better than the bulk powder. For powders with narrow size distributions, the flowability increases significantly with the increase in particle size. In addition, admixing magnesium stearate to ibuprofen not only increases the flow function of the powder, but also reduces the internal friction angle. A theoretical analysis based on the limiting tensile strength of the powder bed was carried out and the flow conditions for particles of different size and shape were developed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18652883     DOI: 10.1016/j.ijpharm.2008.06.023

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  9 in total

1.  Towards integrated drug substance and drug product design for an active pharmaceutical ingredient using particle engineering.

Authors:  Eleftherios Kougoulos; Ian Smales; Hugh M Verrier
Journal:  AAPS PharmSciTech       Date:  2011-01-19       Impact factor: 3.246

2.  Evaluation of granulated lactose as a carrier for DPI formulations 1: effect of granule size.

Authors:  Ping Du; Ju Du; Hugh D C Smyth
Journal:  AAPS PharmSciTech       Date:  2014-06-25       Impact factor: 3.246

3.  The effect of lubricants on powder flowability for pharmaceutical application.

Authors:  Garett Morin; Lauren Briens
Journal:  AAPS PharmSciTech       Date:  2013-07-30       Impact factor: 3.246

4.  An investigation into the effects of excipient particle size, blending techniques and processing parameters on the homogeneity and content uniformity of a blend containing low-dose model drug.

Authors:  Hamad Alyami; Eman Dahmash; James Bowen; Afzal R Mohammed
Journal:  PLoS One       Date:  2017-06-13       Impact factor: 3.240

5.  The effect of the source and the concentration of polymers on the release of chlorhexidine from mucoadhesive buccal tablets.

Authors:  Enas Al-Ani; Claire Martin; Stephen T Britland; Khalid Doudin; David J Hill
Journal:  Saudi Pharm J       Date:  2019-04-20       Impact factor: 4.330

Review 6.  Continuous Formulation Approaches of Amorphous Solid Dispersions: Significance of Powder Flow Properties and Feeding Performance.

Authors:  Edina Szabó; Balázs Démuth; Dorián László Galata; Panna Vass; Edit Hirsch; István Csontos; György Marosi; Zsombor K Nagy
Journal:  Pharmaceutics       Date:  2019-12-05       Impact factor: 6.321

7.  Psilocybin: Characterization of the Metastable Zone Width (MSZW), Control of Anhydrous Polymorphs, and Particle Size Distribution (PSD).

Authors:  Robert B Kargbo; Alexander M Sherwood; Poncho Meisenheimer; Kelsey Lenoch; Solomon Abebe
Journal:  ACS Omega       Date:  2022-02-07

8.  Development of an Age-Appropriate Mini Orally Disintegrating Carvedilol Tablet with Paediatric Biopharmaceutical Considerations.

Authors:  Dilawar Khan; Daniel Kirby; Simon Bryson; Maryam Shah; Afzal Rahman Mohammed
Journal:  Pharmaceutics       Date:  2021-06-03       Impact factor: 6.321

9.  Exploration of Neusilin® US2 as an Acceptable Filler in HPMC Matrix Systems-Comparison of Pharmacopoeial and Dynamic Biorelevant Dissolution Study.

Authors:  Tomáš Bílik; Jakub Vysloužil; Martina Naiserová; Jan Muselík; Miroslava Pavelková; Josef Mašek; Drahomíra Čopová; Martin Čulen; Kateřina Kubová
Journal:  Pharmaceutics       Date:  2022-01-05       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.